Diagnostic chain Metropolis Healthcare on Monday said it will acquire Core Diagnostics for Rs 247 crore. The company's board has approved the acquisition of 100 per cent stake in Core Diagnostics ...

Metropolis Healthcare recently acquired Core Diagnostics for Rs 246.8 crore, marking a consolidation trend in India's ...

New Delhi, Jan 7 (PTI) India has several venture-backed startups for whom the natural consequence is to have an exit, and ...

Core Diagnostics founder Zoya Brar discusses the company's acquisition by Metropolis Healthcare, prioritizing growth over ...

‘No smog, for protection, a shell for consciousness,’ ran the original tagline for the Metropolis jacket by C.P. Company, part of the Italian brand’s seminal Urban Protection range first released in ...

Metropolis Healthcare shares climbed 2.27% to Rs 2,038 after the company announced double-digit revenue growth for Q3FY25, despite it being a seasonally slow period for diagnostics.

Metropolis has a strong presence in South and West India. As of Q2FY25, 50% of the company’s total business came from the West, about 25-26% from the South and the remaining from the North and ...

The acquisition of Core Diagnostics will strengthen Metropolis Healthcare’s portfolio in advanced cancer testing and expand its footprint in northern and eastern India, the Mumbai-listed company said.